• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Qlair
    / Bayer


    Active Ingredient *
    Dienogest 2 mg, 3 mg
    Estradiol Valerate 1, 2, 3 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    1 x 28

    not in the basket chart 33632 17023

    Film Coated Tablets

    3 x 28

    not in the basket chart 33634 17024

    Related information


    Dosage

    Oral use.
    Tablets must be taken in the order directed on the package every day at about the same time with some liquid as needed. Tablet taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet of the previous wallet. Withdrawal bleeding usually starts during the intake of the last tablets of a wallet and may not have finished before the next wallet is started. In some women, the bleeding starts after the first tablets of the new wallet are taken.
    See prescribing information for full details.


    Indications

    Oral contraception.

     


    Contra-Indications

    Presence or a history of venous or arterial thrombotic/thromboembolic events (e.g. deep venous thrombosis, pulmonary embolism, MI) or of a cerebrovascular accident. Presence or history of prodromi of a thrombosis (e.g. TIA, angina pectoris). History of migraine with focal neurological symptoms. Diabetes mellitus with vascular involvement. The presence of a severe or multiple risk factor(s) for venous or arterial thrombosis may also constitute a contraindication. Pancreatitis or a history thereof if associated with severe hypertriglyceridemia. Presence or history of severe hepatic disease as long as liver function values have not returned to normal. Presence or history of liver tumors (benign or malignant). Known or suspected sex-steroid influenced malignancies (e.g. of the genital organs or the breasts). Undiagnosed vaginal bleeding. Known or suspected pregnancy. Hypersensitivity to the active substances or to any of the excipients. Hereditary or acquired predisposition for venous or arterial thrombosis, such as APC-resistance, antithrombin-III-deficiency, protein C deficiency, protein S deficiency, hyperhomocysteinemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).


    Special Precautions

    See prescribing information for full details.


    Side Effects

    Common: Headache, abdominal pain, acne, amenorrhea, breast discomfort, dysmenorrhea, intracyclic bleeding, weight increase.
    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Manufacturer
    Bayer Weimar und co. KG GmbH, Weimar, Germany
    Licence holder
    CLOSE